BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33158970)

  • 21. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
    Menéndez T; Santiago-Vispo NF; Cruz-Leal Y; Coizeau E; Garay H; Reyes O; Batista Y; Cobas K; Carmenate T; Chinea G; Guillén G
    Int J Med Microbiol; 2011 Jan; 301(1):16-25. PubMed ID: 20708963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.
    Ramasamy MN; Clutterbuck EA; Haworth K; Bowman J; Omar O; Thompson AJ; Blanchard-Rohner G; Yu LM; Snape MD; Pollard AJ
    Clin Vaccine Immunol; 2014 Aug; 21(8):1164-8. PubMed ID: 24964805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C.
    Dalal J; Rana R; Harale K; Hanif S; Kumar N; Singh D; Chhikara MK
    Vaccine; 2019 Aug; 37(36):5297-5306. PubMed ID: 31371227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.
    Menéndez T; Carmenate T; Cruz-Leal Y; Coizeau E; Caballero E; Bello D; Guirola M; Alvarez A; Guillén G
    Curr Microbiol; 2010 Feb; 60(2):79-84. PubMed ID: 19771476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal vaccination in pregnancy.
    Abu Raya B; Sadarangani M
    Hum Vaccin Immunother; 2018 May; 14(5):1188-1196. PubMed ID: 29485347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
    Pon RA; Lussier M; Yang QL; Jennings HJ
    J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.
    Morley SL; Cole MJ; Ison CA; Camaraza MA; Sotolongo F; Anwar N; Cuevas I; Carbonero M; Campa HC; Sierra G; Levin M
    Pediatr Infect Dis J; 2001 Nov; 20(11):1054-61. PubMed ID: 11734711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
    Patel M; Lee CK
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001093. PubMed ID: 15674874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
    Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
    Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues surrounding standardization of meningococcal group W135 serology.
    Balmer P; Borrow R
    Vaccine; 2007 Sep; 25 Suppl 1():A63-8. PubMed ID: 17544550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of impact of temperature and pH alterations on the size and antigenicity of meningococcal serogroup A and X polysaccharides and conjugates.
    Sharma N; Hanif S; Rana R; Upadhyay D; Chhikara MK
    Vaccine; 2019 Feb; 37(7):965-972. PubMed ID: 30651197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Changing Epidemiology of Meningococcal Disease.
    Cohn A; MacNeil J
    Infect Dis Clin North Am; 2015 Dec; 29(4):667-77. PubMed ID: 26610420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.